Zobrazeno 1 - 10
of 792
pro vyhledávání: '"Greulich J"'
Autor:
Mercier AM; Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (Drs Mercier, Greulich, Alston, and Racher); and Department of Health Behavior and Health Education, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas (Dr Allison)., Allison MK, Greulich J, Alston A, Racher ML
Publikováno v:
Journal of public health management and practice : JPHMP [J Public Health Manag Pract] 2024 Sep-Oct 01; Vol. 30 (5), pp. 681-687. Date of Electronic Publication: 2024 Jul 22.
Publikováno v:
In Energy Procedia 2012 27:247-252
Publikováno v:
In Energy Procedia 2012 27:234-239
Autor:
Maischner, F., Maus, S., Greulich, J., Lohmüller, S., Lohmüller, E., Saint-Cast, P., Ourinson, D., Vahlman, H., Hergert, K., Riepe, S., Glunz, S., Rein, S.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::4ac10e3401840a3192c5132ef28652fd
https://publica.fraunhofer.de/handle/publica/270553
https://publica.fraunhofer.de/handle/publica/270553
Autor:
Horzel, J., Mack, S., Vulcanean, I.V., Zimmermann, K., Jung, N., Pingel, S., Kwapil, W., Maischner, F., Höffler, H., Bashardoust, S., Wagenmann, D., Greulich, J., Seif, J., Steinmetz, A., Rentsch, J.
8th World Conference on Photovoltaic Energy Conversion; 14-18
Industrial mass production of solar cells is moving towards carrier selective junction solar cells with passivating contacts such as TOPCon, POLO and HJT solar cells. At the same time
Industrial mass production of solar cells is moving towards carrier selective junction solar cells with passivating contacts such as TOPCon, POLO and HJT solar cells. At the same time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be4392118993b9f0b6b3b209313398a4
Autor:
Messmer, C., Schön, J., Lohmüller, S., Greulich, J., Luderer, C., Goldschmidt, J.C., Bivour, M., Glunz, S.W., Hermle, M.
Low-cost and high-efficiency tandem solar cells are promising candidates for a future industrial mass production. Nowadays, the passivated emitter and rear cell (PERC) technology makes up the major market share; therefore, it is an attractive option
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::c12525fff6f0d01d3a904cc86b0c05f3
https://publica.fraunhofer.de/handle/publica/416439
https://publica.fraunhofer.de/handle/publica/416439
Autor:
Preu, R., Rentsch, J., Rein, S., Clement, F., Nekarda, J.F., Saint-Cast, P., Lohmüller, S., Lohmüller, E., Greulich, J., Wöhrle, N., Mack, S., Wolf, A., Pingel, S., Steinmetz, A., Baliozian, P., Goraya, B.S., Nold, S., Glunz, S.W., Bett, A.W.
8th World Conference on Photovoltaic Energy Conversion; 1-6
In 1997, a visionary study addressed limitations of the cost reduction potential for high efficiency solar cell devices. The results of this study triggered increased efforts for the de
In 1997, a visionary study addressed limitations of the cost reduction potential for high efficiency solar cell devices. The results of this study triggered increased efforts for the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::296f055823e802e078613272b275b14d
Publikováno v:
In Energy Procedia 2011 8:694-699
Autor:
Merk D; Cardiovascular Degeneration, Haendeler Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Greulich J; Cardiovascular Degeneration, Altschmied Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Vierkant A; Cardiovascular Degeneration, Altschmied Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Cox F; Cardiovascular Degeneration, Haendeler Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany.; Institute for Translational Pharmacology, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Eckermann O; Cardiovascular Degeneration, Haendeler Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany.; Cardiovascular Degeneration, Altschmied Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., von Ameln F; Cardiovascular Degeneration, Altschmied Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Dyballa-Rukes N; Cardiovascular Degeneration, Haendeler Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany.; Cardiovascular Degeneration, Altschmied Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Altschmied J; Cardiovascular Degeneration, Altschmied Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany.; CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Ale-Agha N; Cardiovascular Degeneration, Haendeler Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany.; CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Jakobs P; Cardiovascular Degeneration, Haendeler Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany., Haendeler J; Cardiovascular Degeneration, Haendeler Group, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany.; CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, 40225 Duesseldorf, Germany.
Publikováno v:
Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2023 Jun 09; Vol. 12 (6). Date of Electronic Publication: 2023 Jun 09.
Currently, the only treatment of end-stage liver diseases is liver transplantation. The worldwide shortage of donor organs and the high number of patients suffering from end-stage liver diseases, require alternative treatment approaches. Therefore, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c90cca82e1761304139c273933b7d4c8
https://doi.org/10.1101/2021.06.09.447730
https://doi.org/10.1101/2021.06.09.447730